Section 5.6 of the January 2024 ProvayBlue label
Section 5.6 of the January 2024 prescribing information for ProvayBlue, an intravenous prescription product, is titled "Effects on Ability to Drive and Operate Machinery." It describes possible confusion, dizziness, and disturbances in vision. This summary identifies the section's subject matter without reproducing its activity recommendations or evaluating an individual's circumstances.
This page provides a descriptive summary of the cited sources, not medical advice, dosing guidance, or instructions for product use or medical action. References to a prescription product concern that product and the cited label version. Source citations do not imply endorsement of MB Dose Log.